Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

Monday, May 13, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. has announced the release date for its financial results for the first quarter of 2024. The results will be disclosed on May 15, 2024, following the end of the quarter on March 31, 2024. This announcement reflects the company's ongoing operations and financial performance.
Price reaction · baseline $0.8 (2024-05-13 close) · hit after-hours · 2 other XTNT headline(s) in the window, move may be shared
day 0 close · peak
+2.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Xtant Medical is focused on surgical solutions for spinal disorders.
  • The upcoming financial results may indicate positive growth.
  • The announcement highlights the company's commitment to transparency.

Full Press Release Details

BELGRADE, Mont. , May 13, 2024 — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after

Frequently Asked Questions

When will Xtant Medical release its Q1 2024 results?

Xtant Medical will release its Q1 2024 financial results on May 15, 2024.

What is the focus of Xtant Medical?

Xtant Medical focuses on surgical solutions for the treatment of spinal disorders.

What date marks the end of Q1 2024 for Xtant Medical?

The first quarter for Xtant Medical ended on March 31, 2024.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical financial results spinal disorders medical technology
Last updated: May 13, 2024

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk